Thomas Tscherning

Vorsitzender bei

Frigoscandia AB

Health Technology

Consumer Services

Commercial Services

Profil

Thomas Tscherning is currently the Chairman at Frigoscandia AB. He was previously the Chairman at Zymenex A, Director at Nereus Pharmaceuticals, Inc., Director at AGC Biologics A, Director at Cellectis SA, Non-Executive Director at F2G Ltd., Director at Halda AB, Director at Warren Pharmaceuticals, Inc., Director at Inzile AB, and Manager & Partner at BI Technology A. He graduated from Karolinska Institutet and received a doctorate degree from the University of Copenhagen in 1995.

Aktive Positionen von Thomas Tscherning

Unternehmen	Position	Beginn
Frigoscandia AB Frigoscandia AB Air Freight/CouriersTransportation Provides temperature-controlled logistics and warehousing services	Vorsitzender	-

Alle aktiven Positionen von Thomas Tscherning

Ehemalige bekannte Positionen von Thomas Tscherning

Unternehmen	Position	Ende
INZILE AB (PUBL)	Direktor/Vorstandsmitglied	23.08.2021
Halda AB Halda AB Electronics DistributorsDistribution Services Provides traffic management and payment administration services	Direktor/Vorstandsmitglied	07.10.2011
BI Technology A/S BI Technology A/S Investment ManagersFinance BI-T is an active venture capital investment manager following a hands-on approach and investing primarily in high-growth life science technology companies with global expansion potential. Investment criteria include an experienced management team, an innovative business concept with a competitive edge based on proven distinctive technology, a clearly defined medical need and patient population, and adequate IP protection by a strong patent portfolio. The firm focuses on unlisted, research-based biotechnology companies dedicated to developing profitable pharmaceuticals for the treatment of human diseases. They pay attention to unmet medical needs, potential medical improvements and major markets. They favor companies with advanced R&D supporting a market launch in the foreseeable future. They invest primarily in Europe, particularly in Denmark and the Nordic countries, and occasionally in the US where they co-invest with third parties. BI-T also invests in the energy technology field, focusing on renewable energy, energy storage, conversion and distribution as well as on improvements to the traditional energy sector. They aim to support the profitable development of sustainable and environmentally-clean alternative energies such as wind, water and solar power as well as clean fuels such as natural gas, hydrogen and biofuels. They invest in Denmark and Europe through direct equity participations in share increases, and target companies with attractive exit potential. They favor startups and early-expansion-stage companies with a credible business model based on proprietary products or services. BI-T provides intensive advisory and consultancy services to their portfolio companies. They follow up their initial investment with additional capital. The firm exits their investments through IPOs and trade sales, and their targeted exit horizon is three to ten years. Finally, the firm is involved in private equity investing in emerging markets in Africa and Asia, particularly in Vietnam, South Africa, East Africa and Egypt. Their investments are often supported by DANIDA-Danish International Development Assistance grants. Investments in Southeast Asia are managed out of a representative office in Ho Chi Minh City, Vietnam.	Private Equity Investor	01.01.2010
ZEALAND PHARMA A/S	Direktor/Vorstandsmitglied	01.01.2010
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Thomas Tscherning im Detail an

Ausbildung von Thomas Tscherning

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Thomas Tscherning im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nereus Pharmaceuticals, Inc. Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutics for cancer, inflammatory, and infectious diseases	Commercial Services
BI Technology A/S BI Technology A/S Investment ManagersFinance BI-T is an active venture capital investment manager following a hands-on approach and investing primarily in high-growth life science technology companies with global expansion potential. Investment criteria include an experienced management team, an innovative business concept with a competitive edge based on proven distinctive technology, a clearly defined medical need and patient population, and adequate IP protection by a strong patent portfolio. The firm focuses on unlisted, research-based biotechnology companies dedicated to developing profitable pharmaceuticals for the treatment of human diseases. They pay attention to unmet medical needs, potential medical improvements and major markets. They favor companies with advanced R&D supporting a market launch in the foreseeable future. They invest primarily in Europe, particularly in Denmark and the Nordic countries, and occasionally in the US where they co-invest with third parties. BI-T also invests in the energy technology field, focusing on renewable energy, energy storage, conversion and distribution as well as on improvements to the traditional energy sector. They aim to support the profitable development of sustainable and environmentally-clean alternative energies such as wind, water and solar power as well as clean fuels such as natural gas, hydrogen and biofuels. They invest in Denmark and Europe through direct equity participations in share increases, and target companies with attractive exit potential. They favor startups and early-expansion-stage companies with a credible business model based on proprietary products or services. BI-T provides intensive advisory and consultancy services to their portfolio companies. They follow up their initial investment with additional capital. The firm exits their investments through IPOs and trade sales, and their targeted exit horizon is three to ten years. Finally, the firm is involved in private equity investing in emerging markets in Africa and Asia, particularly in Vietnam, South Africa, East Africa and Egypt. Their investments are often supported by DANIDA-Danish International Development Assistance grants. Investments in Southeast Asia are managed out of a representative office in Ho Chi Minh City, Vietnam.	Finance
Zymenex A/S Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases	Health Technology
Zealand Pharma A/S Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines	Health Technology
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals	Health Technology
Cellectis SA Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment	Health Technology
Halda AB Halda AB Electronics DistributorsDistribution Services Provides traffic management and payment administration services	Distribution Services
Warren Pharmaceuticals, Inc. Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops tissue-protective technologies	Health Technology
Frigoscandia AB Frigoscandia AB Air Freight/CouriersTransportation Provides temperature-controlled logistics and warehousing services	Transportation
Inzile AB Inzile AB Motor VehiclesConsumer Durables Manufactures and sells electric vehicles for local transportation	Consumer Durables